Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preexisting comorbidities shape the immune response associated with severe COVID-19.
Kreutmair S, Kauffmann M, Unger S, Ingelfinger F, Núñez NG, Alberti C, De Feo D, Krishnarajah S, Friebel E, Ulutekin C, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Göpel S, Rosenberger P, Häberle HA, Ayoub I, Al-Hajj S, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Kreutmair S, et al. Among authors: gaborit b. J Allergy Clin Immunol. 2022 Aug;150(2):312-324. doi: 10.1016/j.jaci.2022.05.019. Epub 2022 Jun 16. J Allergy Clin Immunol. 2022. PMID: 35716951 Free PMC article.
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.
Kreutmair S, Unger S, Núñez NG, Ingelfinger F, Alberti C, De Feo D, Krishnarajah S, Kauffmann M, Friebel E, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Goepel S, Rosenberger P, Häberle HA, Ayoub I, Al-Hajj S, Nilsson J, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Kreutmair S, et al. Among authors: gaborit b. Immunity. 2021 Jul 13;54(7):1578-1593.e5. doi: 10.1016/j.immuni.2021.05.002. Epub 2021 May 9. Immunity. 2021. PMID: 34051147 Free PMC article.
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia.
Kreutmair S, Unger S, Núñez NG, Ingelfinger F, Alberti C, De Feo D, Krishnarajah S, Kauffmann M, Friebel E, Babaei S, Gaborit B, Lutz M, Jurado NP, Malek NP, Goepel S, Rosenberger P, Häberle HA, Ayoub I, Al-Hajj S, Nilsson J, Claassen M, Liblau R, Martin-Blondel G, Bitzer M, Roquilly A, Becher B. Kreutmair S, et al. Among authors: gaborit b. Immunity. 2022 Feb 8;55(2):366-375. doi: 10.1016/j.immuni.2022.01.015. Immunity. 2022. PMID: 35139354 Free PMC article. No abstract available.
Resurgence of BK virus following Covid-19 in kidney transplant recipients.
Masset C, Ville S, Halary F, Gaborit B, Bressolette-Bodin C, Deltombe C, Dujardin A, Jacquemont L, Lebot S, Kervella D, Figueres L, Cantarovich D, Giral M, Hourmant M, Blancho G, Garandeau C, Meurette A, Dantal J. Masset C, et al. Among authors: gaborit b. Transpl Infect Dis. 2021 Feb;23(1):e13465. doi: 10.1111/tid.13465. Epub 2020 Sep 23. Transpl Infect Dis. 2021. PMID: 32939955
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
Gaborit B, Dailly E, Vanhove B, Josien R, Lacombe K, Dubee V, Ferre V, Brouard S, Ader F, Vibet MA, Le Thuaut A, Danger R, Flet L, Omnes A, Berly L, Chiffoleau A, Jobert A, Duvaux O, Raffi F; POLYCOR Trial Group. Gaborit B, et al. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0123721. doi: 10.1128/AAC.01237-21. Epub 2021 Aug 17. Antimicrob Agents Chemother. 2021. PMID: 34181475 Free PMC article. Clinical Trial.
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.
Vanhove B, Marot S, So RT, Gaborit B, Evanno G, Malet I, Lafrogne G, Mevel E, Ciron C, Royer PJ, Lheriteau E, Raffi F, Bruzzone R, Mok CKP, Duvaux O, Marcelin AG, Calvez V. Vanhove B, et al. Among authors: gaborit b. Front Immunol. 2021 Nov 15;12:761250. doi: 10.3389/fimmu.2021.761250. eCollection 2021. Front Immunol. 2021. PMID: 34868003 Free PMC article.
Potential Impact of Rapid Multiplex PCR on Antimicrobial Therapy Guidance for Ventilated Hospital-Acquired Pneumonia in Critically Ill Patients, A Prospective Observational Clinical and Economic Study.
Guillotin F, Poulain C, Gaborit B, Bouras M, Cinotti R, Lakhal K, Vourc'h M, Rozec B, Asehnoune K, Vibet MA, Riche VP, Gibaud SA, Crémet L, Roquilly A. Guillotin F, et al. Among authors: gaborit b. Front Cell Infect Microbiol. 2022 Apr 13;12:804611. doi: 10.3389/fcimb.2022.804611. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35493730 Free PMC article.
Utility of hyposmia and hypogeusia for the diagnosis of COVID-19.
Bénézit F, Le Turnier P, Declerck C, Paillé C, Revest M, Dubée V, Tattevin P; RAN COVID Study Group. Bénézit F, et al. Lancet Infect Dis. 2020 Sep;20(9):1014-1015. doi: 10.1016/S1473-3099(20)30297-8. Epub 2020 Apr 15. Lancet Infect Dis. 2020. PMID: 32304632 Free PMC article. No abstract available.
183 results